ArticleRheumatology international2013

-174G/C interleukin-6 gene promoter polymorphism predicts therapeutic response to etanercept in rheumatoid arthritis.

Ivan Jančić et al.PubMed ↗Publisher ↗

No numbers read from the abstract.